Bioventus (BVS) SVP & General Counsel exercises RSUs, withholds 6,327 shares for taxes

Rhea-AI Filing Summary

Bioventus Inc. SVP & General Counsel Anthony D'Adamio reported equity award activity involving restricted stock units and Class A common stock. On February 15, 2026, he acquired 12,980 shares of Class A common stock at $0.00 per share through the exercise or conversion of restricted stock units, increasing his direct holdings of Class A common stock to 144,396 shares.

On the same date, 6,327 shares of Class A common stock were disposed of at $8.27 per share in a tax-withholding disposition, leaving him with 138,069 directly held shares. Each restricted stock unit represents a contingent right to receive one share of Class A common stock and vests in four equal installments on each of the first four anniversaries of February 15, 2024, subject to his continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

D'Adamio Anthony

(Last) (First) (Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/15/2026		M		12,980	A	$0	144,396	D
Class A Common Stock	02/15/2026		F		6,327	D	$8.27	138,069	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/15/2026		M			12,980	(2)	(2)	Class A Common Stock	12,980	$0	25,960	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Remarks:

	/s/ Anthony D'Adamio	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bioventus (BVS) report for Anthony D'Adamio?

Bioventus reported that Anthony D'Adamio exercised restricted stock units into 12,980 shares of Class A common stock, then disposed of 6,327 shares to cover tax obligations. These transactions reflect equity award vesting mechanics rather than open-market buying or selling.

How many Bioventus (BVS) shares does Anthony D'Adamio hold after this Form 4?

After the reported transactions, Anthony D'Adamio directly holds 138,069 shares of Bioventus Class A common stock. This figure comes after exercising restricted stock units into 12,980 shares and a 6,327-share tax-withholding disposition on February 15, 2026.

What does the RSU exercise on Bioventus (BVS) Form 4 represent?

The RSU exercise represents conversion of 12,980 restricted stock units into an equal number of Bioventus Class A common shares at $0.00 per share. Each RSU is a contingent right to receive one share, tied to service-based vesting conditions over a four-year period.

Was the Bioventus (BVS) insider share disposal an open-market sale?

The 6,327-share disposal was classified as a tax-withholding disposition at $8.27 per share, not an open-market sale. Shares were delivered to satisfy tax obligations arising from the restricted stock unit exercise and vesting, a common feature of equity compensation.

How do Anthony D'Adamio’s Bioventus (BVS) RSUs vest over time?

His restricted stock units vest in four equal installments on each of the first four anniversaries of February 15, 2024. Vesting is conditioned on his continued service through each applicable vesting date, aligning compensation with ongoing employment at Bioventus.

What do the RSUs reported by Bioventus (BVS) entitle Anthony D'Adamio to receive?

Each restricted stock unit entitles him to receive one share of Bioventus Class A common stock upon vesting and settlement. These awards are contingent rights, meaning they convert into shares only as vesting conditions, including continued service, are satisfied over time.